相似文献
1
Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics.
Pharmacol Ther. 2023 Aug;248:108487. doi: 10.1016/j.pharmthera.2023.108487. Epub 2023 Jun 29.
2
The essential role of the transporter ABCG2 in the pathophysiology of erythropoietic protoporphyria.
Sci Adv. 2019 Sep 18;5(9):eaaw6127. doi: 10.1126/sciadv.aaw6127. eCollection 2019 Sep.
3
In ferrochelatase-deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability.
Blood Cells Mol Dis. 2015 Jan;54(1):71-7. doi: 10.1016/j.bcmd.2014.07.017. Epub 2014 Aug 30.
4
Light-provoked skin symptoms on the hands of erythropoietic protoporphyria patients related to personal dosimeter measurements, skin symptoms, light protection and priming.
J Photochem Photobiol B. 2020 Dec;213:112054. doi: 10.1016/j.jphotobiol.2020.112054. Epub 2020 Oct 10.
5
Delta-aminolevulinic acid synthase 2 expression in combination with iron as modifiers of disease severity in erythropoietic protoporphyria.
Mol Genet Metab. 2019 Nov;128(3):304-308. doi: 10.1016/j.ymgme.2019.04.013. Epub 2019 May 2.
6
Erythropoietic protoporphyrias: updates and advances.
Trends Mol Med. 2024 Sep;30(9):863-874. doi: 10.1016/j.molmed.2024.05.006. Epub 2024 Jun 17.
7
Inactivation of protoporphyrin IX in erythrocytes in patients with erythropoietic protoporphyria: A new treatment modality.
Photodiagnosis Photodyn Ther. 2020 Mar;29:101582. doi: 10.1016/j.pdpdt.2019.101582. Epub 2019 Dec 3.
8
Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria.
Cell Chem Biol. 2021 Aug 19;28(8):1221-1234.e6. doi: 10.1016/j.chembiol.2021.02.021. Epub 2021 Mar 22.
9
Erythropoietic Protoporphyria and X-Linked Protoporphyria: pathophysiology, genetics, clinical manifestations, and management.
Mol Genet Metab. 2019 Nov;128(3):298-303. doi: 10.1016/j.ymgme.2019.01.020. Epub 2019 Jan 24.
10
Excessive erythrocyte PPIX influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria.
Cell Mol Biol (Noisy-le-grand). 2009 Feb 16;55(1):45-52.
引用本文的文献
1
Protoporphyrin IX plasma and blood pharmacokinetics and brain tumor distribution determined by a validated LC-MS/MS method.
Sci Rep. 2025 Jul 1;15(1):21521. doi: 10.1038/s41598-025-05780-w.
2
Comparison of Pyrazinamide with Isoniazid for Their Effects on the Heme Biosynthetic Pathway in Mouse Liver.
Metabolites. 2025 May 28;15(6):355. doi: 10.3390/metabo15060355.
3
Combination Effects of Aminolevulinic Acid and Mycophenolic Acid on Hacat Cell Proliferation and Inhibition of Inosine Monophosphate Dehydrogenase.
Molecules. 2025 Mar 18;30(6):1359. doi: 10.3390/molecules30061359.
4
Inhibition of ABCG2 prevents phototoxicity in a mouse model of erythropoietic protoporphyria.
Nat Commun. 2024 Dec 4;15(1):10557. doi: 10.1038/s41467-024-54969-6.
5
Heme (dys)homeostasis and liver disease.
Front Physiol. 2024 Jul 29;15:1436897. doi: 10.3389/fphys.2024.1436897. eCollection 2024.
6
Erythropoietic protoporphyrias: Pathogenesis, diagnosis and management.
Liver Int. 2025 Jan;45(1):e16027. doi: 10.1111/liv.16027. Epub 2024 Jul 16.
7
Third-Generation Anticancer Photodynamic Therapy Systems Based on Star-like Anionic Polyacrylamide Polymer, Gold Nanoparticles, and Temoporfin Photosensitizer.
Molecules. 2024 May 9;29(10):2224. doi: 10.3390/molecules29102224.
8
Photochemical and biological dual-effects enhance the inhibition of photosensitizers for tumour growth.
Chem Sci. 2024 Apr 25;15(20):7757-7766. doi: 10.1039/d4sc00874j. eCollection 2024 May 22.
9
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities.
Cancer Cell Int. 2024 May 4;24(1):157. doi: 10.1186/s12935-024-03329-x.
10
Roles of the ABCG2 Transporter in Protoporphyrin IX Distribution and Toxicity.
Drug Metab Dispos. 2024 Oct 16;52(11):1201-1207. doi: 10.1124/dmd.123.001582.
本文引用的文献
1
Absorption, metabolism, and excretion of [ C]dersimelagon, an investigational oral selective melanocortin 1 receptor agonist, in preclinical species and healthy volunteers.
Pharmacol Res Perspect. 2023 Jun;11(3):e01084. doi: 10.1002/prp2.1084.
2
Results from a first-in-human study of dersimelagon, an investigational oral selective MC1R agonist.
Eur J Clin Pharmacol. 2023 Jun;79(6):801-813. doi: 10.1007/s00228-023-03476-6. Epub 2023 Apr 15.
3
Dersimelagon in Erythropoietic Protoporphyrias.
N Engl J Med. 2023 Apr 13;388(15):1376-1385. doi: 10.1056/NEJMoa2208754.
4
How I treat erythropoietic protoporphyria and X-linked protoporphyria.
Blood. 2023 Jun 15;141(24):2921-2931. doi: 10.1182/blood.2022018688.
5
The Oral Bioavailability and Effect of Various Gastric Conditions on the Pharmacokinetics of Dersimelagon in Healthy Adult Volunteers.
Clin Pharmacol Drug Dev. 2023 May;12(5):493-501. doi: 10.1002/cpdd.1235. Epub 2023 Feb 25.
6
Experimental and approved treatments for skin photosensitivity in individuals with erythropoietic protoporphyria or X-linked protoporphyria: A systematic review.
Biomed Pharmacother. 2023 Feb;158:114132. doi: 10.1016/j.biopha.2022.114132. Epub 2022 Dec 14.
7
Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria.
J Am Acad Dermatol. 2023 Dec;89(6):1227-1237. doi: 10.1016/j.jaad.2022.08.036. Epub 2022 Aug 27.
8
Melanogenic effect of dersimelagon (MT-7117), a novel oral melanocortin 1 receptor agonist.
Skin Health Dis. 2021 Nov 29;2(1):e78. doi: 10.1002/ski2.78. eCollection 2022 Mar.
9
Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria.
Sci Rep. 2022 Apr 12;12(1):6100. doi: 10.1038/s41598-022-10089-z.
10
Blue light induces skin apoptosis and degeneration through activation of the endoplasmic reticulum stress-autophagy apoptosis axis: Protective role of hydrogen sulfide.
J Photochem Photobiol B. 2022 Apr;229:112426. doi: 10.1016/j.jphotobiol.2022.112426. Epub 2022 Mar 10.
Zotero 插件